Revolutionizing Antibody Discovery: MIT’s AI Breakthrough
With this model, researchers may be able to discover antibody drugs capable of targeting a wide range of infectious diseases.
Recursion: Investors Will Need To Be Patient
Stay updated on the volatile share price of Recursion, a biotech company with a maturing pipeline and potential for growth ...
The Bulwark1d
The Best of Times, the Worst of Times for Medicine in America
Our medical tools and techniques are rapidly improving but our system for delivering health care is a source of widespread ...
A Virtual Cell Is a ‘Holy Grail’ of Science. It’s Getting Closer.
Large language models may unlock a new and valuable type of research.
How will AI revolutionize drug development?
The potential of using artificial intelligence in drug discovery and development has sparked both excitement and ...
Nature3d
What will viruses do next? AI is helping scientists predict their evolution
The holy grail of pandemic preparedness is being able to predict how a virus will evolve just by looking at its genetic ...
NVIDIA’s Bold 2025 Predictions: AI and Robots Set to Transform Your Life
Explore how AI and robotics will transform industries, daily life, and science by 2025, with insights from NVIDIA’s top ...
STAT4d
Four years after AlphaFold’s AI ‘solved’ protein structure, a fierce competition lives on
AlphaFold solved a structural biology riddle: predicting protein structure. And yet, CASP, a global competition born to solve ...
AI Could Usher In A Golden Age Of Research But Only If These Cutting-Edge Tools Aren't Restricted To A Few Major Private Companies
In 2015, Microsoft's ResNet surpassed human performance on ImageNet, a test that evaluates the ability of AI systems to carry ...